Comparison of intra-aneurysmal flow modification using optical flow imaging to evaluate the performance of Evolve and Pipeline flow diverting stents

Nicole Mariantonia Cancelliere, Patrick Nicholson, Ivan Radovanovic, Karla Mirella Mendes, Emanuele Orru, Timo Krings, Vitor M Pereira, Nicole Mariantonia Cancelliere, Patrick Nicholson, Ivan Radovanovic, Karla Mirella Mendes, Emanuele Orru, Timo Krings, Vitor M Pereira

Abstract

Background: Flow diverting stent (FDS) devices have revolutionized the treatment of large and complex brain aneurysms, but there is still room for improvement, particularly on the flow diversion properties and technical challenges associated with stent deployment. In this study we compared flow diversion properties between the new generation Surpass Evolve (Stryker) and the Pipeline Flex (Medtronic) devices by quantitatively evaluating intra-aneurysmal flow modification.

Methods: An in vitro experimental set-up was used, consisting of four patient-specific silicone models with internal carotid aneurysms and a circulating hemodynamic simulation system with pulsatile flow. The Evolve and Pipeline stents were deployed across the neck of each aneurysm model, in a randomized fashion, for a total of eight device deployments. A 60 frames/s digital subtraction angiography run was acquired before and after placement of each FDS. An optical flow-analysis method was used to measure intra-aneurysmal flow modification induced by the stent by calculating a mean aneurysm flow amplitude (MAFA) before and after stent placement and computing a ratio.

Results: Average MAFA ratio values calculated from pre- and post-stent placement were significantly lower after deployment of the Evolve (n=4, mean=0.62±0.09) compared with the Pipeline device (n=4, mean=0.71±0.06) (p=0.03).

Conclusions: Our in vitro results show that the Evolve stent had a superior flow diversion effect compared with the Pipeline stent, which-based on clinical evidence-suggest it may promote faster aneurysm occlusion rates in patients.

Keywords: aneurysm; angiography; blood flow; flow diverter.

Conflict of interest statement

Competing interests: VMP is a consultant for Stryker Neurovascular and Medtronic Neurovascular.

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Representative views of 3D Vaso-CT imaging demonstrating wall opposition after angioplasty of both a Pipeline Flex (4.25×25 mm) and a Surpass Evolve (4.25×25 mm) stent, sequentially placed in the same patient-specific silicone aneurysm model. MAFA-R, mean aneurysm flow amplitude ratio.
Figure 2
Figure 2
Representative mean aneurysm flow amplitude analysis displaying averaged detector velocity fields (white dots with lines representing the direction of travel) superimposed on a velocity magnitude color map (m2/s; blue=slower, red=faster) for each flow diverting stent, before and after stent placement. Aneurysm region of interest highlighted in blue. MAFA-R, mean aneurysm flow amplitude ratio.

References

    1. Ye G, Zhang M, Deng L, et al. . Meta-analysis of the efficiency and prognosis of intracranial aneurysm treated with flow diverter devices. J Mol Neurosci 2016;59:158–67. 10.1007/s12031-016-0723-x
    1. Brinjikji W, Murad MH, Lanzino G, et al. . Endovascular treatment of intracranial aneurysms with flow diverters: a meta-analysis. Stroke 2013;44:442–7. 10.1161/STROKEAHA.112.678151
    1. Jou L-D, Chintalapani G, Mawad ME. Metal coverage ratio of pipeline embolization device for treatment of unruptured aneurysms: reality check. Interv Neuroradiol 2016;22:42–8. 10.1177/1591019915617315
    1. Sadasivan C, Cesar L, Seong J, et al. . An original flow diversion device for the treatment of intracranial aneurysms: evaluation in the rabbit elastase-induced model. Stroke 2009;40:952–8. 10.1161/STROKEAHA.108.533760
    1. De Vries J, Boogaarts J, Van Norden A, et al. . New generation of Flow Diverter (surpass) for unruptured intracranial aneurysms: a prospective single-center study in 37 patients. Stroke 2013;44:1567–77. 10.1161/STROKEAHA.111.000434
    1. Pereira VM, Bonnefous O, Ouared R, et al. . A DSA-based method using contrast-motion estimation for the assessment of the intra-aneurysmal flow changes induced by flow-diverter stents. AJNR Am J Neuroradiol 2013;34:808–15. 10.3174/ajnr.A3322
    1. Bonnefous O, Pereira VM, Ouared R, et al. . Quantification of arterial flow using digital subtraction angiography. Med Phys 2012;39:6264–75. 10.1118/1.4754299
    1. Pérez MA, Henkes H, Bouillot P, et al. . Intra-aneurysmal hemodynamics: evaluation of pCONus and pCANvas bifurcation aneurysm devices using DSA optical flow imaging. J Neurointerv Surg 2016;8:1197–201. 10.1136/neurintsurg-2015-011927
    1. Pereira M, Brina O, Bracken J, et al. . E-081 assessment of the MAFA ratio as a quantitative prognostic marker of aneurysm occlusion after flow diverter treatment. J NeuroInterv Surg 2016;8:A84–5.
    1. Sadasivan C, Fiorella D. Preliminary in vitro angiographic comparison of the flow diversion behavior of Evolve and Pipeline devices. J Neurointerv Surg 2019. 10.1136/neurintsurg-2019-015455. [Epub ahead of print: 13 Nov 2019].
    1. Frölich AM, Nawka MT, Ernst M, et al. . Intra-aneurysmal flow disruption after implantation of the Medina® embolization device depends on aneurysm neck coverage. PLoS One 2018;13:e0191975 10.1371/journal.pone.0191975

Source: PubMed

3
Suscribir